Clube; Jasper Rupert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Clube; Jasper Rupert.The latest application filed is for "human targets".

Company Profile

0.34.14

Clube; Jasper Rupert - Cambridge GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment Grant 11,434,305 - Clube September 6, 2	2022-09-06
Methods for treating neurodegenerative diseases using anti-PD-L1 antibodies Grant 10,711,059 - Clube	2020-07-14
Targeting rare human PCSK9 variants for cholesterol treatment Grant 10,618,971 - Clube	2020-04-14
Methods for treating neurodegenerative disease using anti-PD-1 antibodies Grant 10,618,955 - Clube	2020-04-14
Human Targets App 20200109216 - Clube; Jasper Rupert	2020-04-09
Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment Grant 10,611,849 - Clube	2020-04-07
Anti-pd-1 Antibodies For Cns Diseases App 20180222977 - Clube; Jasper Rupert	2018-08-09
Anti-pd-l1 Antibodies For Cns Diseases App 20180215820 - Clube; Jasper Rupert	2018-08-02
Precision Medicine For Cholesterol Treatment App 20180162935 - Clube; Jasper Rupert	2018-06-14
Precision medicine for cholesterol treatment Grant 9,914,769 - Clube March 13, 2	2018-03-13
Methods Of Treating Anaemia App 20160319017 - Clube; Jasper Rupert	2016-11-03
Methods of treating anaemia Grant 9,439,963 - Clube September 13, 2	2016-09-13
Methods of treating anaemia Grant 9,428,578 - Clube August 30, 2	2016-08-30
Precision medicine by targeting VEGF-A variants for treatment of diabetic macular edema and branch retinal vein occlusion Grant 9,416,180 - Clube August 16, 2	2016-08-16
Precision Medicine By Targeting Vegf-a Variants For Treatment Of Diabetic Macular Edema And Branch Retinal Vein Occlusion App 20160229907 - Clube; Jasper Rupert	2016-08-11
Methods of treating anaemia Grant 9,394,568 - Clube July 19, 2	2016-07-19
Methods Of Treating Anaemia App 20160158357 - Clube; Jasper Rupert	2016-06-09
Methods Of Treating Anaemia App 20160159896 - Clube; Jasper Rupert	2016-06-09
Methods Of Treating Anaemia App 20160115545 - Clube; Jasper Rupert	2016-04-28
Methods of treating anaemia Grant 9,303,089 - Clube April 5, 2	2016-04-05
Human Targets V App 20160017051 - Clube; Jasper Rupert	2016-01-21
Methods Of Treating Anaemia App 20160017056 - Clube; Jasper Rupert	2016-01-21
Methods for treating anaemia Grant 9,187,562 - Clube November 17, 2	2015-11-17
Precision Medicine by targeting human NAV1.8 variants for treatment of pain Grant 9,150,660 - Clube October 6, 2	2015-10-06
Precision medicine by targeting human NAV1.9 variants for treatment of pain Grant 9,139,648 - Clube September 22, 2	2015-09-22
Precision medicine by targeting PD-L1 variants for treatment of cancer Grant 9,109,034 - Clube August 18, 2	2015-08-18
Targeting PD-1 variants for treatment of cancer Grant 9,067,998 - Clube June 30, 2	2015-06-30
Targeting rare human PCSK9 variants for cholesterol treatment Grant 9,068,012 - Clube June 30, 2	2015-06-30
Precision Medicine by targeting VEGF-A variants for treatment of retinopathy Grant 9,062,105 - Clube June 23, 2	2015-06-23
Human Targets App 20150166673 - Clube; Jasper Rupert	2015-06-18
Human Targets App 20150166677 - CLUBE; JASPER RUPERT	2015-06-18
Precision Medicine By Targeting Rare Human PCSK9 Variants for Cholesterol Treatment App 20150166672 - Clube; Jasper Rupert	2015-06-18
Targeting rare human PCSK9 variants for cholesterol treatment Grant 9,051,378 - Clube June 9, 2	2015-06-09
Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment Grant 9,045,548 - Clube June 2, 2	2015-06-02
Precision medicine by targeting PD-L1 variants for treatment of cancer Grant 9,045,545 - Clube June 2, 2	2015-06-02
Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment Grant 9,040,052 - Clube May 26, 2	2015-05-26
Targeting rare human PCSK9 variants for cholesterol treatment Grant 9,034,331 - Clube May 19, 2	2015-05-19
Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment Grant 9,034,332 - Clube May 19, 2	2015-05-19
Targeting rare human PCSK9 variants for cholesterol treatment Grant 9,023,359 - Clube May 5, 2	2015-05-05
Method of treating rheumatoid arthritis using antibody to IL6R Grant 9,017,678 - Clube April 28, 2	2015-04-28
Targeting rare human PCSK9 variants for cholesterol treatment Grant 8,999,341 - Clube April 7, 2	2015-04-07
Targeting human NAV1.7 variants for treatment of pain Grant 8,992,927 - Clube March 31, 2	2015-03-31
Targeting human nav1.7 variants for treatment of pain Grant 8,986,694 - Clube March 24, 2	2015-03-24
Method of treating atopic dermatitis or asthma using antibody to IL4RA Grant 8,986,691 - Clube March 24, 2	2015-03-24
Method of treating atopic dermatitis or asthma using antibody to IL4RA Grant 8,980,273 - Clube March 17, 2	2015-03-17
Targeting rare human PCSK9 variants for cholesterol treatment Grant 8,951,523 - Clube February 10, 2	2015-02-10
Method of treating rheumatoid arthritis using antibody to IL6R Grant 8,945,560 - Clube February 3, 2	2015-02-03
Targeting rare human PCSK9 variants for cholesterol treatment Grant 8,883,157 - Clube November 11, 2	2014-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.